Streamline Preferred Stock Total Equity from 2010 to 2025

STRM Stock  USD 3.09  0.05  1.59%   
Streamline Health Preferred Stock Total Equity yearly trend continues to be very stable with very little volatility. Preferred Stock Total Equity is likely to drop to about 7.2 M. During the period from 2010 to 2025, Streamline Health Preferred Stock Total Equity quarterly data regression pattern had sample variance of 9.2 T and median of  8,850,000. View All Fundamentals
 
Preferred Stock Total Equity  
First Reported
2011-07-31
Previous Quarter
8.7 M
Current Value
8.7 M
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Check Streamline Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Streamline Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Total Revenue of 19.1 M or Gross Profit of 9.9 M, as well as many indicators such as Price To Sales Ratio of 1.07, Dividend Yield of 0.0 or PTB Ratio of 1.28. Streamline financial statements analysis is a perfect complement when working with Streamline Health Valuation or Volatility modules.
  
Check out the analysis of Streamline Health Correlation against competitors.

Latest Streamline Health's Preferred Stock Total Equity Growth Pattern

Below is the plot of the Preferred Stock Total Equity of Streamline Health Solutions over the last few years. It is Streamline Health's Preferred Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Streamline Health's overall financial position and show how it may be relating to other accounts over time.
Preferred Stock Total Equity10 Years Trend
Slightly volatile
   Preferred Stock Total Equity   
       Timeline  

Streamline Preferred Stock Total Equity Regression Statistics

Arithmetic Mean7,258,342
Geometric Mean0.00
Coefficient Of Variation41.80
Mean Deviation2,109,467
Median8,850,000
Standard Deviation3,033,884
Sample Variance9.2T
Range10.2M
R-Value0.69
Mean Square Error5.1T
R-Squared0.48
Significance0
Slope442,669
Total Sum of Squares138.1T

Streamline Preferred Stock Total Equity History

20257.2 M
202410.2 M
20168.8 M
2015M
20146.6 M
20135.6 M
20127.8 M

About Streamline Health Financial Statements

Streamline Health investors utilize fundamental indicators, such as Preferred Stock Total Equity, to predict how Streamline Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Preferred Stock Total Equity10.2 M7.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:
Check out the analysis of Streamline Health Correlation against competitors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
12.131
Earnings Share
(2.35)
Revenue Per Share
5.249
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.